OxySure Systems (OXYS) to Host Fourth Quarter and Full Year 2013 Financial Results Conference Call at 9:00 am ET on April 16, 2014
Marketwire - Mon Apr 14, 12:23PM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
OxySure Moves Higher after Obtaining CE Mark
ACCESSWIRE - Mon Apr 07, 8:16AM CDT
Whitefish, MT / ACCESSWIRE / April 7, 2014 / OxySure Systems Inc. (OTCBB: OXYS), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, jumped more than 5% on higher than average volume following its CE Mark announcement and coverage on InvestmentPitch.com on April 2, 2014.
OxySure Systems' Model 615 Portable Emergency Oxygen Device Receives CE Mark Approval for Sale in Europe -- Video News Alert Posted on InvestmentPitch.com
Newsfile Corp - Wed Apr 02, 3:02PM CDT
full story)
OxySure Systems' (OTCQB: OXYS) Model 615 Portable Emergency Oxygen Device Receives CE Mark Approval for Sale in Europe - Video News Alert Hosted on InvestmentPitch.com
Thomson Reuters ONE - Wed Apr 02, 2:44PM CDT
Vancouver, BC, April 2, 2014 - OxySure Systems (OTCQB:OXYS) announced that its OxySure Model 615 portable emergency oxygen device has received CE Mark approval, a critical step toward launching this unique product into the 30 countries belonging to the European Economic Area. OxySure is a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology.
90 Million Patients With Life Threatening Respiratory Disease Need Medical Oxygen Right Now
GlobeNewswire - Wed Apr 02, 9:03AM CDT
According to the World Health Organisation (WHO), 28% of European adults smoke - compared with 18% in the U.S. Tobacco-related illnesses cause 16% of deaths in Europe, compared with 12% globally. Approximately 250,000 people die each year in Europe because of asthma and other respiratory diseases.
OxySure (OXYS) Announces CE Mark Approval for OxySure Model 615 Portable Emergency Oxygen Device
Marketwire - Wed Apr 02, 8:04AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
OxySure Systems (OXYS) Announces Investor Update on Annual Report
Marketwire - Mon Mar 31, 3:11PM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
OxySure Systems (OXYS) to Present at Taglich Brothers 11th Annual Small Cap Equity Conference
Marketwire - Thu Mar 27, 8:15AM CDT
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.
OxySure CEO Provides Shareholders With a "State of the Union" Communication
Marketwire Canada - Mon Mar 03, 8:20AM CST
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company"
Medical Device Innovator OxySure Systems Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Newsfile Corp - Wed Feb 19, 10:18AM CST
full story)
Medical Device Innovator OxySure Systems (OTCQB:OXYS) Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Thomson Reuters ONE - Wed Feb 19, 9:32AM CST
Vancouver, BC, February19, 2014 - OxySure Systems (OTCQB:OXYS) a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, has recent corporate activities summarized in a video by InvestmentPitch. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
Bringing Oxygen from First Response to Public Places
ACCESSWIRE - Tue Feb 18, 8:56AM CST
Emergency oxygen can help improve hypoxia - or insufficient oxygen reaching the cells - and reduce pain and breathing discomfort during breathing and cardiac emergencies. In a 2008 audit of oxygen use in ambulances and emergency departments in the U.K., researchers found that oxygen use in ambulances is very common at 2.2 million episodes each year.
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting
ACCESSWIRE - Mon Feb 03, 9:38AM CST
OxySure Systems Inc. (OTCBB: OXYS), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, recently announced that it removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at above-market conversion prices of between $0.76 and $1.50 per share.
OxySure Systems (OXYS) to Present at SeeThruEquity Microcap Investor Conference
Marketwire - Mon Feb 03, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
OxySure Systems (OXYS) Announces Investor Update Conference Call
Marketwire - Fri Jan 31, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
S&P Capital IQ Initiates Coverage on OxySure Systems, Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Jan 28, 8:36AM CST
S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on OxySure Systems, Inc.
OxySure Systems (OXYS) Improves Balance Sheet by Reducing Debt by Nearly $1 Million
Marketwire - Mon Jan 27, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"
OxySure Systems, Inc. (OXYS) Information to be Available Through S&P Capital IQ's Market Access Program
Marketwire - Wed Jan 22, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) announced today that its company information will be made available via S&P Capital IQ's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of S&P Capital IQ's MarketScope Advisor. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. MarketScope Advisor is an Internet-based research engine used by more than 100,000 investment advisors. A public version of the site is available at http://advisor.marketscope.com
OxySure Systems (OXYS) to Attend the 32nd Annual J.P. Morgan HealthCare Conference in San Francisco
Marketwire - Thu Jan 09, 2:58PM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"